A pilot study of the association of tumor necrosis factor alpha polymorphisms with psoriatic arthritis in the Romanian population

International Journal of Molecular Sciences

Volumn 12, Issue 8, 2011, Pages 5052-5059

  Popa, Olivia M ^a   Bojinca, Mihai ^a   Bojinca, Violeta ^a   Dutescu, Monica I ^b   Meirosu, Mihaela ^c   Caisan, Ruxandra E ^b   Ciofu, Claudia ^a   Bara, Constantin ^a   Popa, Luis O ^d  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b 'Prof Dr C T Nicolau' National Institute of Blood Transfusion   (Romania)

^c ICA Research and Development   (Romania)

^d Grigore Antipa National Museum of Natural History   (Romania)

Author keywords

Psoriatic arthritis; Single nucleotide polymorphism (SNP); Tumor necrosis factor alpha (TNF alpha); Undifferentiated spondyloarthritis

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PROMOTER REGION; PSORIATIC ARTHRITIS; ROMANIA; SINGLE NUCLEOTIDE POLYMORPHISM; SPONDYLOSIS; ALLELE; ARTHRITIS, PSORIATIC; CASE CONTROL STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HEALTH SURVEY; MIDDLE AGED; RISK;

ADULT; ALLELES; ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; ODDS RATIO; PILOT PROJECTS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; ROMANIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052158793     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12085052     Document Type: Article

References (25)

1. Keller, C.; Webb, A.; Davis, J. Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: A brief report and literature review. Ann. Rheum. Dis. 2003, 62, 1128-1132.
2. Kuek, A.; Hazleman, B.L.; Ostor, A.J. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: A medical revolution. Postgrad. Med. J. 2007, 83, 251-260.
3. Baraliakos, X.; Braun, J. Anti-TNF-alpha therapy with infliximab in spondyloarthritides. Expert Rev. Clin. Immunol. 2010, 6, 9-19.
4. Miceli-Richard, C.; Comets, E.; Verstuyft, C.; Tamouza, R.; Loiseau, P.; Ravaud, P.; Kupper, H.; Becquemont, L.; Charron, D.; Mariette, X. A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis. Ann. Rheum. Dis. 2008, 67, 478-484.
5. Raychaudhuri, S.P.; Raychaudhuri, S.K. Biologics: Target-specific treatment of systemic and cutaneous autoimmune diseases. Indian J. Dermatol. 2009, 54, 100-109.
6. Nograles, K.E.; Brasington, R.D.; Bowcock, A.M. New insights into the pathogenesis and genetics of psoriatic arthritis. Nat. Clin. Pract. Rheumatol. 2009, 5, 83-91.
7. Fitzgerald, O.; Winchester, R. Psoriatic arthritis: From pathogenesis to therapy. Arthritis Res. Ther. 2009, 11, 214.
8. Hohler, T.; Grossmann, S.; Stradmann-Bellinghausen, B.; Kaluza, W.; Reuss, E.; de Vlam, K.; Veys, E.; Marker-Hermann, E. Differential association of polymorphisms in the TNFalpha region with psoriatic arthritis but not psoriasis. Ann. Rheum. Dis. 2002, 61, 213-218.
9. Rahman, P.; Siannis, F.; Butt, C.; Farewell, V.; Peddle, L.; Pellett, F.; Gladman, D. TNFalpha polymorphisms and risk of psoriatic arthritis. Ann. Rheum. Dis. 2006, 65, 919-923.
10. Gonzalez, S.; Martinez-Borra, J.; Lopez-Vazquez, A.; Garcia-Fernandez, S.; Torre-Alonso, J.C.; Lopez-Larrea, C. MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis. J. Rheumatol. 2002, 29, 973-978.
11. Nishibu, A.; Oyama, N.; Nakamura, K.; Kaneko, F. Lack of association of TNF-238A and-308A in Japanese patients with psoriasis vulgaris, psoriatic arthritis and generalized pustular psoriasis. J. Dermatol. Sci. 2002, 29, 181-184.
12. Liu, Y.; Helms, C.; Liao, W.; Zaba, L.C.; Duan, S.; Gardner, J.; Wise, C.; Miner, A.; Malloy, M.J.; Pullinger, C.R.; et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 2008, 4, e1000041.
13. Khan, M.A. Update on spondyloarthropathies. Ann. Intern. Med. 2002, 136, 896-907.
14. Zochling, J.; Brandt, J.; Braun, J. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology 2005, 44, 1483-1491.
15. Vargas-Alarcon, G.; Casasola-Vargas, J.; Rodriguez-Perez, J.M.; Huerta-Sil, G.; Perez-Hernandez, N.; Londono, J.; Pacheco-Tena, C.; Cardiel, M.H.; Granados, J.; Burgos-Vargas, R. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum. Immunol. 2006, 67, 826-832.
16. Mastroianni, A.; Minutilli, E.; Mussi, A.; Bordignon, V.; Trento, E.; D'Agosto, G.; Cordiali-Fei, P.; Berardesca, E. Cytokine profiles during infliximab monotherapy in psoriatic arthritis. Br. J. Dermatol. 2005, 153, 531-536.
17. Danning, C.L.; Illei, G.G.; Hitchon, C.; Greer, M.R.; Boumpas, D.T.; McInnes, I.B. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum. 2000, 43, 1244-1256.
18. Kane, D.; Gogarty, M.; O'Leary, J.; Silva, I.; Bermingham, N.; Bresnihan, B.; Fitzgerald, O. Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate. Arthritis Rheum. 2004, 50, 3286-3295.
19. Mease, P.J. Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors. Ann. Rheum. Dis. 2002, 61, 298-304.
20. Garcia-Valladares, I.; Cuchacovich, R.; Espinoza, L.R. Comparative assessment of biologics in treatment of psoriasis: Drug design and clinical effectiveness of ustekinumab. Drug Des. Dev. Ther. 2011, 2011, 41-49.
21. Gonzalez, S.; Brautbar, C.; Martinez-Borra, J.; Lopez-Vazquez, A.; Segal, R.; Blanco-Gelaz, M.A.; Enk, C.D.; Safriman, C.; Lopez-Larrea, C. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum. Immunol. 2001, 62, 632-638.
22. Reich, K.; Huffmeier, U.; Konig, I.R.; Lascorz, J.; Lohmann, J.; Wendler, J.; Traupe, H.; Mossner, R.; Reis, A.; Burkhardt, H. TNF polymorphisms in psoriasis: Association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk allele. Arthritis Rheum. 2007, 56, 2056-2064.
23. Taylor, W.; Gladman, D.; Helliwell, P.; Marchesoni, A.; Mease, P.; Mielants, H. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum. 2006, 54, 2665-2673.
24. Dougados, M.; van der Linden, S.; Juhlin, R.; Huitfeldt, B.; Amor, B.; Calin, A.; Cats, A.; Dijkmans, B.; Olivieri, I.; Pasero, G.; et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991, 34, 1218-1227.
25. Purcell, S.; Neale, B.; Todd-Brown, K.; Thomas, L.; Ferreira, M.A.; Bender, D.; Maller, J.; Sklar, P.; de Bakker, P.I.; Daly, M.J.; et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81, 559-575.